Trelstar® (triptorelin pamoate) is a prescription drug used to treat prostate cancer that has metastasized (spread to other parts of the body). It belongs to a group of medications called gonadotropin-releasing hormone (GnRH) agonists. Like other GnRH agonists, Trelstar slows the growth of prostate cancer cells and reduces symptoms.
Trelstar is given as an intramuscular, or IM, injection (an injection given into the muscle) every one, three, or six months. Each injection will be given by your healthcare provider in a healthcare setting, such as a doctor's office or clinic.
(To learn more about this injection, click Trelstar. This article tells you what you need to know about side effects, safety issues, drug interactions, and more.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 27, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click